VRTX) Break Hurdles and Rise?

VRTX Pharmaceuticals is a biotech company that develops and sells therapies for cystic fibrosis (CF). It has several products for different CF mutations and ages. It also has pipeline candidates for other diseases, such as pain, sickle cell, diabetes, and cancer. It works with various partners on gene editing and RNA technologies. It was founded in 1989 and is based in Boston, Massachusetts.

VRTX stock price was at $947.45 with an intraday increase of 0.82%. Moreover, the intraday trading volume of Vertex is 316.537 K Million less than the 10-day aggregate volume of 323.144 K Million.

Vertex stock has been on an upward trend since 2023 started and has shown buying interest. The stock faced a hurdle near the supply range and had a pullback in the previous sessions.

BlackRock Inc. is the top shareholder of VRTX stock and owns 8.84% of the company, with a current value of $7.9 Billion and a total Vertex share count of 22,820,426. This is as per the information on financial website, Simply Wall St.

The VRTX stock seems to be poised for a significant rise, with potential price growth in the next sessions. The buyers are backing the Vertex stock’s upward movement by striving to maintain these levels.

Based on recent data, the revenue of Q2, 2023 was $2.48 Billion with a net income of 915.70 Million. Moreover, the VRTX stock estimated EPS for Q2’ 23 was 3.86, and the reported EPS was 3.89 which gave a positive surprise of 0.80%. Moreover, the forecasted EPS for the next quarter is positive at 3.91.

Technical Analysis of VRTX Stock Price in 1-D Timeframe

As per price action, Vertex was in a bullish trend from May last year even before 2023 started. The VRTX price found support around $233 and was strongly bought as it was available at a discount. From the low of $233 to the high of $367, the journey was swift and flawlessly upwards, the high was reached by july 21st, 2023. Moreover, the price moved along the Fibonacci levels of 61.80%, 50.00%, 38.20%, and 23.60% for a while and rose steadily from these Fibo levels.

As per the CMP $348.26 (at press time), the price faced some resistance earlier and dropped by pull back to the $339 level, from here it took a rebound and bounced back upwards.

The current stock price of VRTX stock might achieve more, there is a possibility for the price to move toward the next resistance level of $355 and $358.

On the other hand, if the price breaks below the $342 significant support level, it might fall toward $339 and beyond.

At the time of publishing, Vertex Pharmaceuticals Incorporated. (NASDAQ: VRTX) is trading above the 50 and 100 EMA. RSI is around 48, turned neutral as it took 14 SMA support and MACD histogram gap is slim indicating collectively neutral to bullishness.

Summary

The VRTX stock price has risen above $342 to regain bullish momentum and if it holds then it might potentially break the annual high of $367. Technical parameters for VRTX also support the increase in bullish momentum. Vertex Pharmaceuticals Incorporated. (NASDAQ: VRTX) stock prices are bullish on the 1-D time frame as indicators turned bullish. The traders and investors also suggest positive and buying sentiments.

Technical Levels

Support levels: The nearest support levels for VRTX price are $342 and $339.

Resistance levels: The nearest resistance levels for the VRTX stock price are $355 and $358.

Disclaimer

In this article, the views and opinions stated by the author, or any people named are for informational purposes only, and they don’t establish the investment, financial, or any other advice. Trading or investing in cryptocurrency assets comes with a risk of financial loss.